Related Experiment Video
Updated: Sep 6, 2025

15:04
Interactions with and Membrane Permeabilization of Brain Mitochondria by Amyloid Fibrils
Published on: September 28, 2019
6.0K
Amyloid-β aggregates induced by β-cholesteryl glucose-embedded liposomes
Toshinori Shimanouchi1, Yasuhiro Sano1, Kazuma Yasuhara2
1Graduate School of Environmental and Life Science, Okayama University, 3-1-1 Tsushimanaka, kita-kku, Okayama 700-8530, Japan.
Summary
Beta-cholesteryl-D-glucose (β-CG) on liposomes triggers the formation of spherulitic amyloid-beta (Aβ) aggregates, potentially counteracting fibril growth and toxicity in amyloidopathies.
Area of Science:
- Neuroscience
- Biochemistry
- Materials Science
Background:
- Senile plaques, characteristic of Alzheimer's disease, are amyloid depositions primarily composed of aggregated amyloid-beta (Aβ) fibrils.
- Monitoring senile plaque formation on neuronal membranes under physiological conditions is crucial for understanding Alzheimer's disease.
- Amyloid fibril aggregation and associated toxicity are key factors in neurodegenerative amyloidopathies.
Purpose of the Study:
- To investigate the growth behavior of amyloid-beta (Aβ) fibrils in the presence of liposomes incorporating β-cholesteryl-D-glucose (β-CG).
- To elucidate the role of β-CG in inducing and modulating Aβ fibril aggregation on liposomal membranes.
- To explore the potential of β-CG-induced aggregation as a counterbalance to amyloid fibril toxicity.
Main Methods:
- Total internal reflection fluorescence microscopy
- Transmittance electron microscopy
- Spectroscopic methods
Main Results:
- β-CG on liposome membranes induced spontaneous formation of spherulitic Aβ fibrillar aggregates.
- β-CG clusters on liposomes promoted Aβ accumulation and subsequent growth of spherulitic aggregates.
- Compared to cholesterol-induced fibrils, β-CG promoted glucose-induced agglomeration of Aβ fibrils and liposomes, forming spherulitic aggregates.
Conclusions:
- β-CG incorporation into liposomes facilitates the formation of spherulitic Aβ aggregates.
- This glucose-induced agglomeration mechanism may serve as a counterbalance to Aβ fibril growth and toxicity.
- The findings offer potential therapeutic strategies for amyloidopathies by modulating Aβ aggregation.

